Erle T Mast - Net Worth and Insider Trading

Erle T Mast Net Worth

The estimated net worth of Erle T Mast is at least $82,795 dollars as of 2024-05-13. Erle T Mast is the Director of Zogenix Inc and owns about 3,027 shares of Zogenix Inc (ZGNX) stock worth over $80,760. Erle T Mast is the Executive VP and CFO of Clovis Oncology Inc and owns about 135,583 shares of Clovis Oncology Inc (CLVSQ) stock worth over $2,034. Erle T Mast is also the Director of Sienna Biopharmaceuticals Inc and owns about 6,700 shares of Sienna Biopharmaceuticals Inc (SNNAQ) stock worth over $1. Details can be seen in Erle T Mast's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Erle T Mast has not made any transactions after 2022-02-01 and currently still holds the listed stock(s).

Transaction Summary of Erle T Mast

To

Erle T Mast Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erle T Mast owns 3 companies in total, including Zogenix Inc (ZGNX) , Sienna Biopharmaceuticals Inc (SNNAQ) , and Clovis Oncology Inc (CLVSQ) .

Click here to see the complete history of Erle T Mast’s form 4 insider trades.

Insider Ownership Summary of Erle T Mast

Ticker Comapny Transaction Date Type of Owner
ZGNX Zogenix Inc 2022-02-01 director
SNNAQ Sienna Biopharmaceuticals Inc 2018-06-01 director
CLVSQ Clovis Oncology Inc 2015-11-02 Executive VP and CFO

Erle T Mast Latest Holdings Summary

Erle T Mast currently owns a total of 3 stocks. Among these stocks, Erle T Mast owns 3,027 shares of Zogenix Inc (ZGNX) as of February 1, 2022, with a value of $80,760 and a weighting of 97.54%. Erle T Mast owns 135,583 shares of Clovis Oncology Inc (CLVSQ) as of November 2, 2015, with a value of $2,034 and a weighting of 2.46%. Erle T Mast also owns 6,700 shares of Sienna Biopharmaceuticals Inc (SNNAQ) as of August 1, 2017, with a value of $1 and a weighting of 0%.

Latest Holdings of Erle T Mast

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZGNX Zogenix Inc 2022-02-01 3,027 26.68 80,760
CLVSQ Clovis Oncology Inc 2015-11-02 135,583 0.02 2,034
SNNAQ Sienna Biopharmaceuticals Inc 2017-08-01 6,700 0.00 1

Holding Weightings of Erle T Mast


Erle T Mast Form 4 Trading Tracker

According to the SEC Form 4 filings, Erle T Mast has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zogenix Inc is the sale of 1,250 shares on February 1, 2022, which brought Erle T Mast around $32,550.

According to the SEC Form 4 filings, Erle T Mast has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 3,000 shares on November 2, 2015, which brought Erle T Mast around $316,680.

According to the SEC Form 4 filings, Erle T Mast has made a total of 0 transactions in Sienna Biopharmaceuticals Inc (SNNAQ) over the past 5 years. The most-recent trade in Sienna Biopharmaceuticals Inc is the acquisition of 6,700 shares on August 1, 2017, which cost Erle T Mast around $100,500.

Insider Trading History of Erle T Mast

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erle T Mast Trading Performance

GuruFocus tracks the stock performance after each of Erle T Mast's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erle T Mast is 35.5%. GuruFocus also compares Erle T Mast's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erle T Mast within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Erle T Mast's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Erle T Mast

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.24
Relative Return to S&P 500(%) 11.36

Erle T Mast Ownership Network

Ownership Network List of Erle T Mast

No Data

Ownership Network Relation of Erle T Mast


Erle T Mast Owned Company Details

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Erle T Mast is the director of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zogenix Inc Insider Transactions

No Available Data

Erle T Mast Mailing Address

Above is the net worth, insider trading, and ownership report for Erle T Mast. You might contact Erle T Mast via mailing address: C/o Spiros Development Corp Ii Inc, 7475 Lusk Blvd, San Diego Ca 92121.

Discussions on Erle T Mast

No discussions yet.